Collaborative Arrangements (Tables)

3 Months Ended

Mar. 31, 2017

Collaborative Arrangements

Schedule of net revenue recognized under GSK Agreements

	Three months ended March 31,
(In thousands)	2017			2016
Royalties from a related party - RELVAR/BREO	$	38,689		$	24,287
Royalties from a related party - ANORO	5,038			3,124
Total royalties from a related party	43,727			27,411
Less: amortization of capitalized fees paid to a related party	(3,456		)	(3,456		)
Royalty revenue	40,271			23,955
Strategic alliance - MABA program license	221			221
Total net revenue from GSK	$	40,492		$	24,176